M A Goldsmith, S K Carter. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Bleomycin/therapeutic useCarmustine/therapeutic useCyclohexanesCyclophosphamide/therapeutic useDrug EvaluationDrug Therapy, CombinationHodgkin Disease/drug therapyHodgkin Disease/radiotherapyItalyMechlorethamine/therapeutic useNitrosourea Compounds/therapeutic usePrednisone/therapeutic useProcarbazine/therapeutic useRemission, SpontaneousUnited StatesVinblastine/therapeutic useVincristine/therapeutic use
Substances: See more » CyclohexanesNitrosourea CompoundsBleomycinProcarbazineMechlorethamineVincristineVinblastineCyclophosphamideCarmustinePrednisone
Year: 1974 PMID: 4129559 DOI: 10.1002/1097-0142(197401)33:1<1::aid-cncr2820330102>3.0.co;2-t
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860